vs
Side-by-side financial comparison of Lifeway Foods, Inc. (LWAY) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.
Lifeway Foods, Inc. is the larger business by last-quarter revenue ($55.4M vs $41.8M, roughly 1.3× Neuronetics, Inc.). Lifeway Foods, Inc. runs the higher net margin — 4.6% vs -17.2%, a 21.8% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 18.0%). Neuronetics, Inc. produced more free cash flow last quarter ($692.0K vs $-17.4M). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 11.4%).
Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
LWAY vs STIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.4M | $41.8M |
| Net Profit | $2.5M | $-7.2M |
| Gross Margin | 27.8% | 52.0% |
| Operating Margin | 6.8% | -12.1% |
| Net Margin | 4.6% | -17.2% |
| Revenue YoY | 18.0% | 85.7% |
| Net Profit YoY | 1688.1% | 43.2% |
| EPS (diluted) | $0.15 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.4M | $41.8M | ||
| Q3 25 | $57.1M | $37.3M | ||
| Q2 25 | $53.9M | $38.1M | ||
| Q1 25 | $46.1M | $32.0M | ||
| Q4 24 | $46.9M | $22.5M | ||
| Q3 24 | $46.1M | $18.5M | ||
| Q2 24 | $49.2M | $16.4M | ||
| Q1 24 | $44.6M | $17.4M |
| Q4 25 | $2.5M | $-7.2M | ||
| Q3 25 | $3.5M | $-9.0M | ||
| Q2 25 | $4.2M | $-10.1M | ||
| Q1 25 | $3.5M | $-12.7M | ||
| Q4 24 | $-160.0K | $-12.7M | ||
| Q3 24 | $3.0M | $-13.3M | ||
| Q2 24 | $3.8M | $-9.8M | ||
| Q1 24 | $2.4M | $-7.9M |
| Q4 25 | 27.8% | 52.0% | ||
| Q3 25 | 28.7% | 45.9% | ||
| Q2 25 | 28.6% | 46.6% | ||
| Q1 25 | 23.9% | 49.2% | ||
| Q4 24 | 25.3% | 66.2% | ||
| Q3 24 | 25.7% | 75.6% | ||
| Q2 24 | 27.0% | 74.0% | ||
| Q1 24 | 25.8% | 75.1% |
| Q4 25 | 6.8% | -12.1% | ||
| Q3 25 | 8.8% | -19.6% | ||
| Q2 25 | 10.8% | -21.1% | ||
| Q1 25 | 3.4% | -34.4% | ||
| Q4 24 | 1.5% | -51.0% | ||
| Q3 24 | 9.1% | -41.7% | ||
| Q2 24 | 11.0% | -51.7% | ||
| Q1 24 | 8.0% | -39.4% |
| Q4 25 | 4.6% | -17.2% | ||
| Q3 25 | 6.2% | -24.3% | ||
| Q2 25 | 7.9% | -26.6% | ||
| Q1 25 | 7.7% | -39.6% | ||
| Q4 24 | -0.3% | -56.4% | ||
| Q3 24 | 6.5% | -72.0% | ||
| Q2 24 | 7.7% | -59.8% | ||
| Q1 24 | 5.4% | -45.2% |
| Q4 25 | $0.15 | $-0.10 | ||
| Q3 25 | $0.23 | $-0.13 | ||
| Q2 25 | $0.28 | $-0.15 | ||
| Q1 25 | $0.23 | $-0.21 | ||
| Q4 24 | $0.00 | $-0.34 | ||
| Q3 24 | $0.19 | $-0.44 | ||
| Q2 24 | $0.25 | $-0.33 | ||
| Q1 24 | $0.16 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $28.1M |
| Total DebtLower is stronger | — | $65.8M |
| Stockholders' EquityBook value | $85.8M | $22.4M |
| Total Assets | $105.6M | $141.6M |
| Debt / EquityLower = less leverage | — | 2.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $28.1M | ||
| Q3 25 | $23.0M | $28.0M | ||
| Q2 25 | $21.2M | $11.0M | ||
| Q1 25 | $19.4M | $20.2M | ||
| Q4 24 | $16.7M | $18.5M | ||
| Q3 24 | $20.6M | $20.9M | ||
| Q2 24 | $14.6M | $42.6M | ||
| Q1 24 | $12.0M | $47.7M |
| Q4 25 | — | $65.8M | ||
| Q3 25 | — | $65.7M | ||
| Q2 25 | — | $55.5M | ||
| Q1 25 | — | $55.3M | ||
| Q4 24 | — | $55.2M | ||
| Q3 24 | — | $46.0M | ||
| Q2 24 | — | $59.8M | ||
| Q1 24 | $2.5M | $59.4M |
| Q4 25 | $85.8M | $22.4M | ||
| Q3 25 | $82.8M | $27.4M | ||
| Q2 25 | $78.7M | $27.1M | ||
| Q1 25 | $74.2M | $35.5M | ||
| Q4 24 | $71.9M | $27.7M | ||
| Q3 24 | $71.5M | $9.4M | ||
| Q2 24 | $68.0M | $19.4M | ||
| Q1 24 | $63.5M | $27.7M |
| Q4 25 | $105.6M | $141.6M | ||
| Q3 25 | $109.5M | $145.5M | ||
| Q2 25 | $98.3M | $134.7M | ||
| Q1 25 | $93.7M | $142.0M | ||
| Q4 24 | $90.5M | $140.9M | ||
| Q3 24 | $91.3M | — | ||
| Q2 24 | $84.9M | $96.8M | ||
| Q1 24 | $82.8M | $103.8M |
| Q4 25 | — | 2.94× | ||
| Q3 25 | — | 2.40× | ||
| Q2 25 | — | 2.05× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 4.90× | ||
| Q2 24 | — | 3.08× | ||
| Q1 24 | 0.04× | 2.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $267.0K | $908.0K |
| Free Cash FlowOCF − Capex | $-17.4M | $692.0K |
| FCF MarginFCF / Revenue | -31.5% | 1.7% |
| Capex IntensityCapex / Revenue | 31.9% | 0.5% |
| Cash ConversionOCF / Net Profit | 0.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.4M | $-21.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $267.0K | $908.0K | ||
| Q3 25 | $6.9M | $-785.0K | ||
| Q2 25 | $3.9M | $-3.5M | ||
| Q1 25 | $-150.0K | $-17.0M | ||
| Q4 24 | $-2.6M | $-8.6M | ||
| Q3 24 | $7.5M | $-5.4M | ||
| Q2 24 | $6.5M | $-5.0M | ||
| Q1 24 | $1.5M | $-12.0M |
| Q4 25 | $-17.4M | $692.0K | ||
| Q3 25 | $1.8M | $-899.0K | ||
| Q2 25 | $1.6M | $-3.8M | ||
| Q1 25 | $-2.4M | $-17.2M | ||
| Q4 24 | $-3.8M | $-8.7M | ||
| Q3 24 | $5.9M | $-5.8M | ||
| Q2 24 | $5.1M | $-5.6M | ||
| Q1 24 | $-923.0K | $-12.4M |
| Q4 25 | -31.5% | 1.7% | ||
| Q3 25 | 3.1% | -2.4% | ||
| Q2 25 | 3.0% | -9.9% | ||
| Q1 25 | -5.1% | -53.8% | ||
| Q4 24 | -8.2% | -38.6% | ||
| Q3 24 | 12.8% | -31.3% | ||
| Q2 24 | 10.4% | -34.0% | ||
| Q1 24 | -2.1% | -71.1% |
| Q4 25 | 31.9% | 0.5% | ||
| Q3 25 | 9.0% | 0.3% | ||
| Q2 25 | 4.3% | 0.7% | ||
| Q1 25 | 4.8% | 0.7% | ||
| Q4 24 | 2.7% | 0.4% | ||
| Q3 24 | 3.3% | 2.1% | ||
| Q2 24 | 2.9% | 3.7% | ||
| Q1 24 | 5.5% | 2.2% |
| Q4 25 | 0.11× | — | ||
| Q3 25 | 1.96× | — | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | -0.04× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.50× | — | ||
| Q2 24 | 1.73× | — | ||
| Q1 24 | 0.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
STIM
Segment breakdown not available.
